Publication | Closed Access

Allosteric interactions between the oxytocin receptor and the β2-adrenergic receptor in the modulation of ERK1/2 activation are mediated by heterodimerization

Molecular PharmacologyMolecular PhysiologySignal TransductionG Protein-coupled ReceptorCell SignalingMedicinePhysiologyMechanism Of ActionReceptor (Biochemistry)Allosteric InteractionsPharmacologyCellular PhysiologyOxytocin ReceptorErk1/2 Activation